This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
Increases speed to market for drug developers working on nucleic acid therapeutics
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
New solvent-free micronization technology expanded at the Darmstadt site in Germany
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
More than 10,000 scientific publications containing EUDRAGIT
Subscribe To Our Newsletter & Stay Updated
